Gilead Sciences Stock Quote GIS - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

88.47

Bid

88.28

Ask

88.37

Volume

1,697

87.25 Day's Range 88.48

57.18 52 Week Range 92.77

Market Cap

110.257B

Previous Close

87.73

Open

87.79

Last Trade

88.47

Last Trade Time

10:42:13

Financial Volume

VWAP

Average Volume (3m)

5,794

Shares Outstanding

1,246,265,857

Dividend Yield

3.55%

PE Ratio

19.83

Earnings Per Share (EPS)

4.55

Revenue

27.12B

Net Profit

5.67B

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.gilead.com

Headquarters

Wilmington, Delaware, USA

Founded

Gilead Sciences Inc is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker GIS. The last closing price for Gilead Sciences was 87.73 €. Over the last year, Gilead Sciences shares have traded in a share price range of 57.18 € to 92.77 €.

Gilead Sciences currently has 1,246,265,857 shares outstanding. The market capitalization of Gilead Sciences is 109.33 € billion. Gilead Sciences has a price to earnings ratio (PE ratio) of 19.83.

Gilead and Genesis team up on using AI to develop novel therapeutics

Gilead Sciences Inc on Tuesday announced a strategic collaboration with Genesis Therapeutics Inc to discover and deve ...

Gilead notes transfer of Yescarta marketing authorisation from Daiichi

Gilead Sciences Inc on Thursday said that the marketing authorisation in Japan for its chimeric antigen receptor T-ce ...

GLOBAL BUSINESS: Bristol-Myers wins approval for Breyanzi in Japan

The following is a round-up of updates by global companies, issued on Tuesday and not separately reported by Alliance ...

World Health Organisation 'strongly recommends' Pfizer's covid pill

The World Health Organization said Friday it "strongly recommended" Pfizer Inc's covid-19 antiviral pill Paxlovid for ...

TOP NEWS: GSK's ViiV gets USD1.25 billion from Gilead patent pact

GlaxoSmithKline PLC on Wednesday said majority-owned investee ViiV Healthcare has agreed to settle a global patent in ...

Gilead Sciences receives expedited approval for antiviral drug Veklury

Gilead Sciences Inc on Friday said that the US Food & Drug Administration granted its Veklury drug expedited approval ...

Gilead and Merck & Co HIV double drug combo starts Phase 2 study

Gilead Sciences Inc and Merck & Co Inc announced Tuesday the start of a Phase 2 clinical study evaluating an investig ...

Gilead Sciences Teams Up With Vir To Develop Chronic Hepatitis B Cure

Gilead Sciences Inc on Tuesday said it has entered into a clinical collaboration with Vir Biotechnology Inc focused o ...

Gilead Sciences Ups Annual Guidance As Covid-19 Drug Boosts Sales

Gilead Sciences Inc on Monday said it has increased its product sales guidance for 2020 as one of its drugs used to t ...

Gilead's Kite, Oxford BioTherapeutics Partner On Cell Therapy Research

Kite, a Gilead Sciences Inc portfolio company, on Wednesday said it and Oxford BioTherapeutics Ltd have entered into ...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.06	-0.0677736360556	88.53	89	85.709999	2921	87.54280638	DE
4	0.97	1.10857142857	87.5	90.51	85.709999	3704	88.56641582	DE
12	8.6	10.7674971829	79.87	92.77	79.33	5794	86.8737825	DE
26	24.34	37.9541556214	64.13	92.77	63.43	4917	79.78530402	DE
52	9.730001	12.3571261412	78.739999	92.77	57.18	5175	72.34883642	DE
156	25.21	39.8514068922	63.26	92.77	52.06	4384	71.17261485	DE
260	29.53	50.1017984391	58.94	92.77	46.165	10735	65.52143164	DE

GIS - Frequently Asked Questions (FAQ)

What is the current Gilead Sciences share price?

The current share price of Gilead Sciences is 88.47 €

How many Gilead Sciences shares are in issue?

Gilead Sciences has 1,246,265,857 shares in issue

What is the market cap of Gilead Sciences?

The market capitalisation of Gilead Sciences is EUR 109.33B

What is the 1 year trading range for Gilead Sciences share price?

Gilead Sciences has traded in the range of 57.18 € to 92.77 € during the past year

What is the PE ratio of Gilead Sciences?

The price to earnings ratio of Gilead Sciences is 19.83

What is the cash to sales ratio of Gilead Sciences?

The cash to sales ratio of Gilead Sciences is 4.14

What is the reporting currency for Gilead Sciences?

Gilead Sciences reports financial results in USD

What is the latest annual turnover for Gilead Sciences?

The latest annual turnover of Gilead Sciences is USD 27.12B

What is the latest annual profit for Gilead Sciences?

The latest annual profit of Gilead Sciences is USD 5.67B

What is the registered address of Gilead Sciences?

The registered address for Gilead Sciences is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Gilead Sciences website address?

The website address for Gilead Sciences is www.gilead.com

Which industry sector does Gilead Sciences operate in?

Gilead Sciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SG7Sage Therapeutics Inc	7.382 € (36.10%)	4.92k
L7C2Windfall Geotek Inc	0.0115 € (35.29%)	2.54k
23IIntraCellular Therapies Inc	125.00 € (34.41%)	2.67k
VOPInvestigator Resources Ltd	0.017 € (30.77%)	26.47k
YW5Giant Mining Corp	0.266 € (30.39%)	176.64k
GSPComstock Inc	0.262 € (-49.13%)	272.99k
QJ4Auric Minerals Corp	1.36 € (-48.92%)	690.9k
KASHIntellabridge Technology Corp	0.0255 € (-48.48%)	300
7M0ASpectra7 Microsystems Inc	0.0635 € (-34.54%)	2k
0PV2Moovly Media Inc	0.002 € (-33.33%)	621
D7GNel ASA	0.199 € (-18.87%)	19.57M
PF8European Lithium Limited	0.032 € (-4.19%)	6.02M
0QJHexagon Purus ASA	0.3785 € (-10.73%)	2.53M
76M0Realbotix Corp	0.466 € (17.68%)	2.35M
RQ0DWave Quantum Inc	4.088 € (-27.36%)	2.04M